Byoung Chul Park Selected Research

Byoung Chul Park Research Topics

Disease

14	Neoplasms (Cancer) 01/2021 - 03/2004
4	Hypoxia (Hypoxemia) 11/2023 - 11/2005
2	Parkinson Disease (Parkinson's Disease) 01/2023 - 06/2019
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2016 - 08/2004
2	Colorectal Neoplasms (Colorectal Cancer) 03/2012 - 01/2012
2	Obesity 12/2011 - 05/2009
2	Neoplasm Metastasis (Metastasis) 06/2011 - 01/2009
1	Genomic Instability 11/2023
1	Neuroinflammatory Diseases 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 03/2019
1	Lung Neoplasms (Lung Cancer) 12/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2018
1	Inflammation (Inflammations) 12/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 09/2012
1	Infections 01/2012
1	Circulating Neoplastic Cells 01/2012
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2012
1	Adenocarcinoma 06/2011
1	Stomach Neoplasms (Stomach Cancer) 06/2011
1	Osteoporosis 10/2010
1	Hematologic Diseases (Blood Diseases) 09/2010
1	Neuroblastoma 08/2010
1	Colonic Neoplasms (Colon Cancer) 06/2010
1	Hepatocellular Carcinoma (Hepatoma) 11/2009
1	Carcinogenesis 11/2009
1	Liver Cell Adenoma (Hepatocellular Adenoma) 11/2009
1	Clonorchiasis 06/2009
1	Anaplastic Thyroid Carcinoma 04/2009
1	Melanoma (Melanoma, Malignant) 01/2009
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2004

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2004
3	AntigensIBA 03/2012 - 06/2009
3	ProteomeIBA 06/2011 - 01/2009
2	Oxygen (Dioxygen)IBA 11/2023 - 11/2005
2	Transcription Factors (Transcription Factor)IBA 11/2020 - 01/2015
2	Phosphotransferases (Kinase)IBA 01/2020 - 08/2010
2	Superoxide Dismutase-1IBA 11/2016 - 08/2004
2	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2016 - 08/2004
2	UbiquitinIBA 11/2016 - 08/2004
1	DNA Transposable Elements (Element, IS)IBA 11/2023
1	licochalcone DIBA 01/2023
1	Neuroprotective AgentsIBA 01/2023
1	SynucleinsIBA 01/2023
1	snake venom protein C activatorIBA 06/2021
1	Proteolysis Targeting ChimeraIBA 06/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Deubiquitinating EnzymesIBA 01/2021
1	XenobioticsIBA 11/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2020
1	GSK-2816126IBA 09/2020
1	pomalidomideIBA 09/2020
1	Dopamine (Intropin)FDA LinkGeneric 06/2019
1	(+)-JQ1 compoundIBA 03/2019
1	Apoptosis Regulatory ProteinsIBA 12/2018
1	LipopolysaccharidesIBA 12/2017
1	Dual-Specificity PhosphatasesIBA 12/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2017
1	Transcription Factor 3IBA 09/2012
1	HLA-A*02:01 antigenIBA 03/2012
1	EpitopesIBA 03/2012
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2012
1	Messenger RNA (mRNA)IBA 01/2012
1	CytokinesIBA 01/2012
1	CateninsIBA 12/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2011
1	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2011
1	ClusterinIBA 05/2011
1	Glycoproteins (Glycoprotein)IBA 05/2011
1	Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA 10/2010
1	HaptoglobinsIBA 09/2010
1	Small Interfering RNA (siRNA)IBA 08/2010
1	Interleukin-12 Subunit p40IBA 06/2010
1	VaccinesIBA 06/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2010
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 12/2009
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 12/2009
1	hepatitis B virus X proteinIBA 11/2009
1	Protein Kinases (Protein Kinase)IBA 10/2009
1	Cysteine Proteases (Cysteine Protease)IBA 06/2009
1	asparaginylendopeptidase (legumain)IBA 06/2009
1	Indicators and Reagents (Reagents)IBA 04/2009
1	NSC-87877IBA 04/2009
1	Tyrosine (L-Tyrosine)FDA Link 01/2009
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2005
1	Biomarkers (Surrogate Marker)IBA 11/2004
1	Molecular Chaperones (Chaperone, Molecular)IBA 08/2004
1	Retinoblastoma ProteinIBA 03/2004
1	E2F Transcription FactorsIBA 03/2004

Therapy/Procedure

4	Therapeutics 06/2019 - 06/2009
3	Immunotherapy 03/2012 - 06/2010